Perry Hackett – University of Minnesota Innovator
2,082 views · Published 29 March 2017 · 2:13 · Indexed 4 November 2026
Channel: University of Minnesota · 2017 · Education
Perry Hackett’s Sleeping Beauty Transposon System is a gene transfer platform that can be used to reprogram the human immune system to find and attack cancer cells. Up to 80 percent of people who receive therapies based on the technology experience disease remission or complete recovery. Last year, two biotech companies licensed a cancer treatment involving Sleeping Beauty to pharmaceutical company Merck for nearly $1 billion. The technology has also helped launch gene editing companies in other fields, such as agriculture, and has been used in basic research by thousands of researchers across the globe. A professor in the College of Biological Sciences, Hackett was the winner of the 2017 Impact Award.
More from this channel
-
2:24
U of M at the Minnesota State Fair
-
2:09
U of M offers class on I-35W bridge collapse
-
2:04
UMC Football 2007 season preview
-
2:26
Trojan Ranks U of M #1 in Sexual Health
-
2:19
Ken Burns and "The War" at the U of M
-
0:36
Driven to Discover: What's the future of virtual technology?
-
2:00
University of Minnesota Rochester Opens New Campus
-
2:21
U of M neutrino lab may shed light on dark matter